Table of Content

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DESIGN 19
2.2 RESEARCH APPROACH 20
2.2.1 RESEARCH METHODOLOGY STEPS 20
2.2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 21
2.2.2.1 Secondary research 21
2.2.2.2 Secondary sources 21
2.2.2.3 Primary research 22
2.2.2.4 Primary sources 23
2.2.2.5 Key insights from primary sources 23
2.3 MARKET SIZE ESTIMATION METHODOLOGY 24
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 25
2.5 ASSUMPTIONS 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHTS 30
4.1 NEUROSURGERY DEVICES: MARKET OVERVIEW 30
4.2 NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE,
2019 VS. 2024 (USD MILLION) 30
4.3 DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 31
4.4 NEUROSURGERY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 32
?

5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 33
5.2.1.1 Research into expanding applications of neuromodulation 33
5.2.1.2 Benefits of neuroendoscopic surgery over conventional brain surgery 34
5.2.1.3 Rising prevalence of neurological diseases 35
5.2.2 RESTRAINTS 35
5.2.2.1 High cost of neuroendoscopy procedures and equipment 35
5.2.3 OPPORTUNITIES 35
5.2.3.1 Emerging economies 35
5.2.4 CHALLENGES 36
5.2.4.1 Dearth of trained professionals 36

6 NEUROSURGERY DEVICES MARKET, BY PRODUCT 37
6.1 INTRODUCTION 38
6.2 NEUROMODULATION DEVICES 39
6.2.1 INTERNAL NEUROMODULATION DEVICES 39
6.2.2 SPINAL CORD STIMULATION DEVICES 40
6.2.2.1 SCS devices dominate the internal neuromodulation devices market as they are cost-efficient 40
6.2.3 DEEP BRAIN STIMULATION DEVICES 41
6.2.3.1 Growing prevalence of Parkinson’s disease and other neurological disorders to fuel market growth 41
6.2.4 OTHER INTERNAL NEUROMODULATION DEVICES 42
6.3 EXTERNAL NEUROMODULATION DEVICES 43
6.3.1 RISING DEMAND FOR NONINVASIVE NEUROMODULATION TECHNIQUES TO DRIVE THE ADOPTION OF EXTERNAL NEUROMODULATION DEVICES 43
6.4 NEUROENDOSCOPY DEVICES 44
6.4.1 LOW COST, SMALLER INCISIONS, AND REDUCED HOSPITAL STAY ARE SOME OF THE ADVANTAGES ASSOCIATED WITH NEUROENDOSCOPY DEVICES 44

7 NEUROSURGERY DEVICES MARKET, BY APPLICATION 46
7.1 INTRODUCTION 47
7.2 SPINAL CORD STIMULATION MARKET 47
7.2.1 CHRONIC PAIN 48
7.2.1.1 Spinal cord stimulation is the standard procedure for patients with chronic pain 48
7.2.2 FAILED BACK SURGERY SYNDROME (FBSS) 49
7.2.2.1 Treatments such as chiropractic and acupressure are expected to hamper the growth of the neurosurgery devices market for FBSS 49
7.2.3 ISCHEMIA 50
7.2.3.1 High incidence of ischemia to drive the demand for neurosurgery devices 50
7.3 DEEP BRAIN STIMULATION MARKET 50
7.3.1 PARKINSON’S DISEASE 52
7.3.1.1 Rising incidence of Parkinson’s and the growing number of researches conducted in this field to drive market growth 52
7.3.2 TREMOR 52
7.3.2.1 Rising geriatric population and the high efficacy of DBS to support market growth 52
7.3.3 DEPRESSION 53
7.3.3.1 DBS therapies to treat depression involve activating the brain directly with magnets, implants, and electricity 53
7.3.4 OTHER DBS APPLICATIONS 54
7.4 NEUROENDOSCOPY 54
7.4.1 TRANSNASAL NEUROENDOSCOPY 55
7.4.1.1 Transnasal neuroendoscopy is indicated for biopsies, removal of cysts, and removal of pituitary gland tumors 55
7.4.2 INTRAVENTRICULAR NEUROENDOSCOPY 56
7.4.2.1 Ease of use, increased visibility, and treatment of a large number of neurological conditions?key advantages of intraventricular neuroendoscopy 56
7.4.3 TRANSCRANIAL NEUROENDOSCOPY 57
7.4.3.1 Transcranial approach is more invasive as compared to the transnasal neuroendoscopic approach 57

8 NEUROSURGERY DEVICES MARKET, BY REGION 58
8.1 INTRODUCTION 59
8.2 NORTH AMERICA 60
8.2.1 US 63
8.2.1.1 The US dominates the North American neurosurgery devices market due to the high prevalence of traumatic brain injuries 63
8.2.2 CANADA 66
8.2.2.1 Favorable government initiatives to support market growth in Canada 66
8.3 EUROPE 69
8.3.1 GERMANY 72
8.3.1.1 The strong presence of key neurosurgery equipment manufacturers to support market growth 72
8.3.2 UK 75
8.3.2.1 High burden of brain tumors to fuel market growth 75
8.3.3 FRANCE 77
8.3.3.1 Rising geriatric population and the associated increase in the prevalence of neurological disorders to drive the demand for neurosurgery devices 77
8.3.4 ROE 80
8.4 ASIA PACIFIC 83
8.5 REST OF THE WORLD 87
?

9 COMPETITIVE LANDSCAPE 91
9.1 OVERVIEW 91
9.2 MARKET SHARE ANALYSIS 92
9.2.1 INTRODUCTION 92
9.3 COMPETITIVE LEADERSHIP MAPPING 94
9.3.1 VISIONARY LEADERS 94
9.3.2 INNOVATORS 95
9.3.3 DYNAMIC DIFFERENTIATORS 95
9.3.4 EMERGING COMPANIES 95
9.4 COMPETITIVE SCENARIO 97
9.4.1 PRODUCT LAUNCHES 97
9.4.2 EXPANSIONS 97
9.4.3 ACQUISITIONS 98
9.4.4 JOINT VENTURES 98

10 COMPANY PROFILES 99
(Business overview, Products offered, Recent developments, MNM view)*
10.1 B. BRAUN MELSUNGEN 99
10.2 MEDTRONIC 101
10.3 BOSTON SCIENTIFIC CORPORATION 103
10.4 NEVRO CORPORATION 105
10.5 KARL STORZ 107
10.6 ABBOTT 108
10.7 ACKERMANN INSTRUMENTE 110
10.8 ADEOR MEDICAL 111
10.9 HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS 112
10.10 MACHIDA ENDOSCOPE CO., LTD. 113
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

11 APPENDIX 114
11.1 DISCUSSION GUIDE 114
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 117
11.3 AVAILABLE CUSTOMIZATIONS 119
11.4 RELATED REPORTS 119
11.5 AUTHOR DETAILS 120



List of Figures



FIGURE 1 RESEARCH DESIGN: NEUROSURGERY DEVICES MARKET 19
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 22
FIGURE 3 NEUROSURGERY DEVICES MARKET: BOTTOM-UP APPROACH 24
FIGURE 4 NEUROSURGERY DEVICES MARKET: TOP-DOWN APPROACH 24
FIGURE 5 DATA TRIANGULATION METHODOLOGY 25
FIGURE 6 NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION) 27
FIGURE 7 NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2019 VS. 2024 (USD MILLION) 28
FIGURE 8 NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2019 VS. 2024 (USD MILLION) 28
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE NEUROSURGERY DEVICES MARKET 29
FIGURE 10 GROWING PREVALENCE OF NEUROLOGICAL DISEASES TO DRIVE
MARKET GROWTH 30
FIGURE 11 CHRONIC PAIN SEGMENT WILL CONTINUE TO DOMINATE THE SPINAL CORD STIMULATION APPLICATIONS MARKET IN 2024 30
FIGURE 12 PARKINSON’S DISEASE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE DEEP BRAIN STIMULATION APPLICATIONS MARKET IN 2018 31
FIGURE 13 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD 32
FIGURE 14 NEUROSURGERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES 33
FIGURE 15 NEUROMODULATION DEVICES TO WITNESS THE HIGHEST GROWTH IN
THE FORECAST PERIOD 38
FIGURE 16 SPINAL CORD STIMULATION DEVICES SEGMENT DOMINATES THE INTERNAL NEUROMODULATION DEVICES MARKET 40
FIGURE 17 CHRONIC PAIN SEGMENT WILL CONTINUE TO DOMINATE THE SPINAL CORD STIMULATION APPLICATIONS MARKET IN 2024 47
FIGURE 18 PARKINSON’S DISEASE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE DEEP BRAIN STIMULATION APPLICATIONS MARKET IN 2018 51
FIGURE 19 TRANSCRANIAL NEUROENDOSCOPY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE NEUROENDOSCOPY APPLICATIONS MARKET 55
FIGURE 20 NORTH AMERICA DOMINATES THE NEUROSURGERY DEVICES 59
FIGURE 21 NORTH AMERICA: NEUROSURGERY DEVICES MARKET SNAPSHOT 60
FIGURE 22 EUROPE: NEUROSURGERY DEVICES MARKET SNAPSHOT 69
FIGURE 23 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET SNAPSHOT 84
FIGURE 24 ROW: NEUROSURGERY DEVICES MARKET SNAPSHOT 88
FIGURE 25 KEY DEVELOPMENTS IN THE NEUROSURGERY DEVICES MARKET, 2017–2019 91
FIGURE 26 NEUROENDOSCOPY: MARKET SHARE RANKING, BY KEY PLAYER (2018) 92
FIGURE 27 NEUROMODULATION: MARKET SHARE RANKING, BY KEY PLAYER (2018) 93
FIGURE 28 NEUROSURGERY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2018) 96
FIGURE 29 B. BRAUN MELSUNGEN: COMPANY SNAPSHOT (2018) 99
FIGURE 30 MEDTRONIC: COMPANY SNAPSHOT (2018) 101
?
FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2018) 103
FIGURE 32 NEVRO CORPORATION: COMPANY SNAPSHOT (2018) 105
FIGURE 33 ABBOTT: COMPANY SNAPSHOT (2018) 108

 

List of Tables



TABLE 1 INDICATIVE LIST OF NEUROMODULATION CLINICAL TRIALS 34
TABLE 2 NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 38
TABLE 3 NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 39
TABLE 4 INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 40
TABLE 5 SPINAL CORD STIMULATION DEVICES MARKET, BY REGION 2017–2024 (USD MILLION) 41
TABLE 6 DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION 2017–2024 (USD MILLION) 42
TABLE 7 OTHER INTERNAL NEUROMODULATION DEVICES MARKET, BY REGION 2017–2024 (USD MILLION) 43
TABLE 8 EXTERNAL NEUROMODULATION DEVICES MARKET, BY REGION 2017–2024 (USD MILLION) 44
TABLE 9 NEUROENDOSCOPY DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 45
TABLE 10 SPINAL CORD STIMULATION APPLICATIONS MARKET, BY TYPE 2017–2024 (USD MILLION) 47
TABLE 11 CHRONIC PAIN APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 48
TABLE 12 FAILED BACK SURGERY SYNDROME APPLICATIONS MARKET, BY REGION 2017–2024 (USD MILLION) 49
TABLE 13 ISCHEMIA APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 14 DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY TYPE 2017–2024 (USD MILLION) 51
TABLE 15 PARKINSON’S DISEASE APPLICATIONS MARKET, BY REGION 2017–2024 (USD MILLION) 52
TABLE 16 TREMOR APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 53
TABLE 17 DEPRESSION APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 53
TABLE 18 OTHER DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY REGION 2017–2024 (USD MILLION) 54
TABLE 19 NEUROENDOSCOPY APPLICATIONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 55
TABLE 20 TRANSNASAL NEUROENDOSCOPY APPLICATIONS MARKET, BY REGION 2017–2024 (USD MILLION) 56
TABLE 21 INTRAVENTRICULAR NEUROENDOSCOPY APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 57
TABLE 22 TRANSCRANIAL NEUROENDOSCOPY APPLICATIONS MARKET, BY REGION 2017–2024 (USD MILLION) 57
TABLE 23 NEUROSURGERY DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 59
TABLE 24 NORTH AMERICA: NEUROSURGERY DEVICES MARKET, BY COUNTRY 2017–2024 (USD MILLION) 61
TABLE 25 NORTH AMERICA: NEUROSURGERY DEVICES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 61
TABLE 26 NORTH AMERICA: NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 61
TABLE 27 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 62
TABLE 28 NORTH AMERICA: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION) 62
TABLE 29 NORTH AMERICA: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION) 62
TABLE 30 NORTH AMERICA: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION) 63
TABLE 31 US: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 64
TABLE 32 US: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 64
TABLE 33 US: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 64
TABLE 34 US: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION) 65
TABLE 35 US: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION) 65
TABLE 36 US: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION) 65
TABLE 37 CANADA: NEUROSURGERY DEVICES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 66
TABLE 38 CANADA: NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 67
TABLE 39 CANADA: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 67
TABLE 40 CANADA: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION BY TYPE, 2017–2024 (USD MILLION) 67
TABLE 41 CANADA: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION BY TYPE, 2017–2024 (USD MILLION) 68
TABLE 42 CANADA: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION) 68
TABLE 43 EUROPE: NEUROSURGERY DEVICES MARKET, BY COUNTRY 2017–2024 (USD MILLION) 70
TABLE 44 EUROPE: NEUROSURGERY DEVICES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 70
TABLE 45 EUROPE: NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 70
TABLE 46 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 71
TABLE 47 EUROPE: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION BY TYPE, 2017–2024 (USD MILLION) 71
TABLE 48 EUROPE: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION BY TYPE, 2017–2024 (USD MILLION) 71
TABLE 49 EUROPE: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION) 72
TABLE 50 GERMANY: NEUROSURGERY DEVICES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 73
TABLE 51 GERMANY: NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 73
TABLE 52 GERMANY: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 73
TABLE 53 GERMANY: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION) 74
TABLE 54 GERMANY: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION BY TYPE, 2017–2024 (USD MILLION) 74
TABLE 55 GERMANY: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION) 74
TABLE 56 UK: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 75
TABLE 57 UK: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 76
TABLE 58 UK: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 76
TABLE 59 UK: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION) 76
TABLE 60 UK: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION) 77
TABLE 61 UK: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION) 77
TABLE 62 FRANCE: NEUROSURGERY DEVICES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 78
TABLE 63 FRANCE: NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 78
TABLE 64 FRANCE: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 79
TABLE 65 FRANCE: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION BY TYPE, 2017–2024 (USD MILLION) 79
TABLE 66 FRANCE: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION BY TYPE, 2017–2024 (USD MILLION) 79
TABLE 67 FRANCE: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION) 80
TABLE 68 ROE: NEUROSURGERY DEVICES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 81
TABLE 69 ROE: NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 81
TABLE 70 ROE: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 81
TABLE 71 ROE: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION BY TYPE, 2017–2024 (USD MILLION) 82
TABLE 72 ROE: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION BY TYPE, 2017–2024 (USD MILLION) 82
TABLE 73 ROE: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION) 82
TABLE 74 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 84
TABLE 75 ASIA PACIFIC: NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 85
TABLE 76 ASIA PACIFIC: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 85
TABLE 77 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION) 85
TABLE 78 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION) 86
TABLE 79 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION) 86
TABLE 80 ROW: NEUROSURGERY DEVICES MARKET, BY PRODUCT 2017–2024 (USD MILLION) 88
TABLE 81 ROW: NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 89
TABLE 82 ROW: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE 2017–2024 (USD MILLION) 89
TABLE 83 ROW: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 84 ROW: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION BY TYPE, 2017–2024 (USD MILLION) 90
TABLE 85 ROW: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION) 90
TABLE 86 PRODUCT LAUNCHES (2017–2019) 97
TABLE 87 EXPANSIONS (2017–2019) 97
TABLE 88 ACQUISITIONS (2017–2019) 98
TABLE 89 JOINT VENTURES (2017–2019) 98